ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gamble, E.
Right arrow Articles by Jeffery, P.K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gamble, E.
Right arrow Articles by Jeffery, P.K.
Eur Respir J 2003; 22:992-995
Copyright ©ERS Journals Ltd 2003


Variation of CD8+ T-lymphocytes around the bronchial internal perimeter in chronic bronchitis

E. Gamble1,2, W. Burns1, J. Zhu1, T. Ansari1, V. De Rose3, J. Kips4, N.C. Barnes2 and P.K. Jeffery1

1 Lung Pathology, Dept of Gene Therapy, Imperial College London at the Royal Brompton Hospital, and 2 Dept of Respiratory Medicine, London Chest Hospital, London, UK. 3 Dept of Clinical and Biological Sciences, Respiratory Disease Division, University of Turin, Turin, Italy. 4 Dept of Respiratory Diseases, Gent University Hospital, Gent, Belgium.

CORRESPONDENCE: P.K. Jeffery, Lung Pathology, Imperial College London, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK. Fax: 44 2073518435. E-mail: p.jeffery@ic.ac.uk

Keywords: airway, inflammation, smokers, variability

Received: December 12, 2002
Accepted August 8, 2003


    Abstract
 TOP
 Abstract
 Methods
 Results
 Discussion
 References
 
The variation of CD8+ cells has been determined around the internal perimeter of intrapulmonary bronchi in smokers with chronic bronchitis (CB), and the amount of tissue required to confidently estimate the true mean has been calculated.

Lung specimens were obtained from 10 smokers with CB. Paraffin sections of intrapulmonary bronchi were immunostained and CD8+ cells counted in the epithelium and subepithelium in up to 10 sequential 1-mm segments around the internal perimeter of each airway.

The percentage of counts falling between ±20% of the final mean was 43.0% for epithelium and 40.9% for subepithelium. In 90% of subjects, the cumulative mean was stable after examination of subepithelial tissue associated with 5 mm of reticular basement membrane.

There is considerable variation in the counts of CD8+ cells between adjacent 1-mm airway mucosal segments in chronic bronchitis. In order to achieve a representative count and to maximise statistical power to detect differences between study populations, subepithelial tissue including a minimum of 5 mm of reticular basement membrane length should be examined.

Chronic bronchitis (CB) and chronic obstructive pulmonary disease (COPD) are associated with an inflammatory infiltrate in large and small airways 14. Increased numbers of activated T-lymphocytes and macrophages have been demonstrated by immunohistochemical staining 5. In the presence of airflow limitation (i.e. forced expiratory volume in one second (FEV1) <80% predicted) there is a significant increase in the CD8+ T-lymphocyte subset 6 and FEV1 % pred has been shown to be inversely related to CD8+ cell count 7.

Few studies have examined biopsy variability in smokers with CB. Sampling of airway mucosa sufficient to account for intrasubject variability must be considered when planning any biopsy study. Given the wide variation of biopsy sampling in practice, the authors felt it would be helpful to have further data with which to make informed decisions. Such data have important implications in the planning of studies where bronchial wall tissue parameters are a main end-point. This study examines the variability of CD8+ T-lymphocyte counts in CB around the internal perimeter of intrapulmonary bronchi. The results described herein give an indication of the minimum quantity of tissue that needs to be examined in order to obtain a representative cell count for the entire airway in section.


    Methods
 TOP
 Abstract
 Methods
 Results
 Discussion
 References
 
Subjects
Lung resection specimens were obtained from current smokers and one exsmoker with CB undergoing resection for lung tumour. CB was defined as cough productive of sputum occurring on most days of the month for ≥3 months per year for 2 yrs before the study 8. Subjects had been free from exacerbations during the month preceding the study; an exacerbation was defined as increased dyspnoea associated with a change in the quality or quantity of sputum leading to the subject seeking additional medical attention. Two patients met the Global Initiative for Obstructive Lung Disease criteria for mild COPD and two for moderate COPD 9. Mean FEV1 % pred was 89% (range 69–119%). Mean FEV1/forced vital capacity ratio was 75% (range 65–96%). Demographic and lung function data are given in table 1Go. Appropriate tissue sections were selected from the tissue archive. These had been obtained for and also used in a previously published study 10. Ten tissue sections from 10 patients including intrapulmonary bronchi cut in transverse section with ≥7 mm of intact reticular basement membrane (RBM) and associated epithelium and subepithelium were selected. All airways included cartilage and glands. Figure 1Go is a photomicrograph of one of the airways used. Paraffin-embedded sections were dewaxed to tap water prior to immunohistological processing. The avidin-biotinylated peroxidase complex technique was used to identify CD8+ cells as described previously 10.


View this table:
[in this window]
[in a new window]
 
Table 1 Subject characteristics

 


View larger version (167K):
[in this window]
[in a new window]
 
Fig. 1.— Photomicrograph of an airway in cross-section at low power. Scale bar=0.5 mm.

 
Quantification
An intrapulmonary bronchus cut in transverse section with ≥7 mm of intact RBM and associated epithelium and subepithelium was selected from each tissue section. CD8+ T-lymphocytes were counted in both the epithelium and subepithelium to a depth of 100 µm in up to 10 sequential segments around the internal perimeter each composed of a 1-mm length of RBM. For one subject, one airway from each of two separate tissue sections was counted to determine variation between airways. Imaging and quantification was carried out with a Zeiss light microscope (Thornwood, NY, USA) and x40 objective lens with eyepiece graticule by a single observer. The internal airway perimeter was measured using computerised image analysis. The intraobserver coefficient of variation (CV) was 4% for subepithelial and 9% for epithelial CD8+ cells, respectively. The interobserver CV was 5% for subepithelial and 18% for epithelial CD8+ cells, respectively.

Statistical analysis
The CV was calculated as the sd/mean expressed as a percentage. Data were also analysed descriptively. Final mean cell counts were calculated for each subject by dividing the total cell count in all segments by the total RBM length examined. Cumulative means were calculated as the results of counts of each additional segment were added. The proportion of single-segment counts that were within 20% of the final mean for each individual was determined. The number of segments that had been counted before the cumulative mean, remaining within 20% of the final mean value, was also established and at this point the cumulative mean was considered to be stable.


    Results
 TOP
 Abstract
 Methods
 Results
 Discussion
 References
 
One bronchus from each of 10 subjects was examined and from these 93x1-mm segments of mucosa were of sufficient quality to be analysed. The mean airway internal perimeter was 12.49 mm (range 7.57–19.55 mm). Figure 2Go shows the subepithelial cell count from each segment for each airway for the 10 subjects studied. Of the 93x1-mm segments of mucosa assessed, the CD8+ cell count fell within 20% of the final mean value in 43.0% of segments for epithelium and 40.9% of segments for subepithelium. Counts for the epithelium varied by >50% from the final mean in 24% of 1-mm segments. For the subepithelium, counts varied by 50% from the final mean in 18% of 1-mm segments. Figure 3Go shows the single-segment subepithelial cell count/final mean as a percentage for the 10 subjects studied. Although most values cluster around the mean, there are a small number of values that depart markedly from the mean. The mean count was stable for 80% of subjects after examination of 6 mm of epithelial tissue and for 90% of subjects after examination of 5 mm of subepithelial tissue. The mean was stable for all counts after examination of tissue in which a length of 9-mm RBM was included. The CV (using data from 10 segments) for two different airways from the same subject was 4.6% for epithelial and 22.6% for subepithelial counts, respectively. The CV for 10 individual 1-mm segment counts from the same subject was 14.4% for epithelial and 80.8% for subepithelial counts, respectively.



View larger version (10K):
[in this window]
[in a new window]
 
Fig. 2.— Each dot represents the absolute CD8 count for a single 1-mm mucosal segment from subjects A to J.

 


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3.— Each dot represents the percentage of the final mean CD8 count for that subject for a single 1-mm mucosal segment. Dotted lines indicate the range ±50% of the final mean CD8 count.

 

    Discussion
 TOP
 Abstract
 Methods
 Results
 Discussion
 References
 
In sampling airway mucosa it is assumed that the biopsy obtained will be representative of the entire airway in cross-section. However, this is not proven, and the intrinsic variability in the distribution of inflammatory cells within airway tissue must be taken into account so that adequate sampling can be performed. Examination of more tissue is likely to provide a more representative cell count for the airway. However, the quantity of tissue that can be sampled and examined is limited by practical considerations.

Few studies have addressed the issue of how much endobronchial biopsy tissue should be examined to obtain a representative cell count and hence to maximise statistical power to detect a difference between study populations. There is a paucity of data and it is unclear whether the results of such studies in asthma can be extrapolated to a group of smokers with CB or COPD. Sullivan et al. 11 examined the variation in inflammatory cell numbers between step sections of a bronchial biopsy from subjects with asthma, COPD and healthy controls. Inflammatory cells did not follow a normal frequency distribution, so the quantity of tissue required could not be predicted linearly. By descriptive analysis they recommended examination of a zone of RBM of ≥7 mm length to a depth of 60 µm (i.e. 0.42 mm2). ten Hacken etal.12 using bronchial biopsies from healthy controls andsubjects with asthma, demonstrated that tissue of 1.0x0.1 mm in size (0.1 mm2), along 1-mm RBM was sufficient to obtain constant cell numbers. Sont et al. 13 examined variability between fields within a single section and between different airway sites in patients with asthma. They found satisfactory correlation between two areas of average size 0.035 mm2.

While the variation in cell counts between tissue sections of a single biopsy in COPD has been studied 11, the variation of 1-mm segments (equivalent to a biopsy sample) around the internal perimeter of an airway has not been examined. To the best of the authors' knowledge, this study is the first to report variation in CD8+ cell count around the internal perimeter of an airway and to use such data to estimate the quantity of tissue that should be examined to provide accurate estimates of inflammatory cell counts. Such knowledge should allow investigators to improve study design and increase the power to detect differences between-study populations.

From the results of the present study, examination of a single 1-mm segment of mucosal tissue gave a subepithelial CD8+ count of acceptable accuracy on only 41% of occasions. A significant minority of 1-mm segments fell wide (>±50%) of the final mean value. These results suggest that subepithelial tissue associated with ≥5 mm of RBM should be examined in order to obtain a representative subepithelial CD8+ cell count. The findings of Sullivan et al. 11 demonstrate that inflammatory cells are not randomly distributed throughout large airway subepithelial tissue but tend to cluster. This could account for a large part of the variation observed in this study between 1-mm tissue samples. Increasing the quantity of tissue assessed will provide a more representative result and the study by Sullivan et al. 11 indicated that at least three bronchial biopsies, each of 2 mm size should be counted. The present study of intrapulmonary bronchi would support the need to aim for this quantity of tissue. The variability observed herein was greater than that of intraobserver variation. Interestingly, the CV between 1-mm segments from the same airway was substantially higher than the CV between two airways from the same subject indicating the importance of sampling adequately from each airway.

There is considerable variation in counts of CD8+ cells between adjacent 1-mm segments of mucosa in smokers with chronic bronchitis. These results suggest that subepithelial tissue associated with ≥5 mm of reticular basement membrane should be examined in order to achieve a representative cell count for the airway and maximise statistical power to detect group differences.


    References
 TOP
 Abstract
 Methods
 Results
 Discussion
 References
 

  1. Fournier M, Lebargy F, Le Roy Ladurie F, Lenormand E, Pariente R. Intraepithelial T-lymphocyte subsets in the airways of normal subjects and of patients with chronic bronchitis. Am Rev Respir Dis 1989;140:737–742.[ISI][Medline] [Order article via Infotrieve]
  2. Lacoste J-Y, Bousquet J, Chanez P, et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993;92:537–548.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  3. Mullen JBM, Wright JL, Wiggs BR, Pare PD, Hogg JC. Reassessment of inflammation of airways in chronic bronchitis. BMJ 1985;291:1235–1239.
  4. Saetta M. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:822–826.[Abstract/Free Full Text]
  5. Saetta M, Di Stefano A, Maestrelli P, et al. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993;147:301–306.[ISI][Medline] [Order article via Infotrieve]
  6. Lams BE, Sousa AR, Rees PJ, Lee TH. Subepthelial immunopathology of large airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J 2000;15:512–516.[Abstract]
  7. O'Shaughnessy T, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T-lymphocytes with FEV1. Am J Respir Crit Care Med 1997;155:852–857.[Abstract]
  8. Medical Research Council. Report: Definition and classification of chronic bronchitis (for clinical and epidemiological purposes). Lancet 1965;1:775–779.[Medline] [Order article via Infotrieve]
  9. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. National Heart, Lung and Blood Institute/World Health Organziation Global Initiative for Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001;163:1256–1276.[Free Full Text]
  10. Zhu J, Majumdar S, Qiu Y, et al. Interleukin-4 and interleukin-5 gene expression and inflammation in the mucus-secreting glands and subepithelial tissue of smokers with chronic bronchitis. Am J Respir Crit Care Med 2001;164:2220–2228.[Abstract/Free Full Text]
  11. Sullivan P, Stephens D, Ansari T, Costello J, Jeffery PK. Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies. Eur Respir J 1998;12:811–815.[Abstract]
  12. ten Hacken NH, Aleva RM, Oosterhoff Y, et al. Submucosa 1.0x0.1 mm in size is sufficient to count inflammatory cell numbers in human airway biopsy specimens. Mod Pathol 1998;11:292–294.[ISI][Medline] [Order article via Infotrieve]
  13. Sont JK, Willems LN, Evertse CE, Hooijer R, Sterk PJ, van Krieken JH. Repeatability of measures of inflammatory cell number in bronchial biopsies in atopic asthma. Eur Respir J 1997;10:2602–2608.[Abstract]



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
J. Zhu, Y. Qiu, M. Valobra, S. Qiu, S. Majumdar, D. Matin, V. De Rose, and P. K. Jeffery
Plasma Cells and IL-4 in Chronic Bronchitis and Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., June 1, 2007; 175(11): 1125 - 1133.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. L. Carroll, N. G. Carroll, and A. L. James
Do bronchial biopsies represent mast cell density in airways? A stereological study
Eur. Respir. J., September 1, 2006; 28(3): 612 - 621.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
E. Gamble, Y. Qiu, D. Wang, J. Zhu, A. M. Vignola{dagger}, C. Kroegel, F. Morell, T. T. Hansel, I. D. Pavord, K. F. Rabe, et al.
Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design
Eur. Respir. J., February 1, 2006; 27(2): 293 - 299.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gamble, E.
Right arrow Articles by Jeffery, P.K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gamble, E.
Right arrow Articles by Jeffery, P.K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS